Recent reports suggest that Pasireotide-induced diabetes is mediated by a rapid impairment of insulin secretion without different insulin sensitivity, especially in older acromegalic patients with poor baseline glycemic control [28]. The gene discussed is INS; the disease is diabetes mellitus.